(Q43824339)

27 November 2017

title

Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis (English)

1 reference

27 November 2017

0 references

Feng P

1

1 reference

27 November 2017

Chan SH

2

1 reference

27 November 2017

Soo MY

3

1 reference

27 November 2017

Liu D

4

1 reference

27 November 2017

Guan M

5

1 reference

27 November 2017

Ren EC

6

1 reference

27 November 2017

Hu H

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

92

1 reference

27 November 2017

issue

7

1 reference

27 November 2017

page(s)

1872-1880

1 reference

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

A soluble recombinant fusion protein of the transmembrane envelope protein of equine infectious anaemia virus for ELISA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

21 January 2018

Nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1872%3A%3AAID-CNCR1704%3E3.0.CO%3B2-N

10.1002/1097-0142(20011001)92:7<1872::AID-CNCR1704>3.0.CO;2-N

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference